3b Blackbio Dx Ltd vs Global Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1332 as of 23 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Global Health Ltd changed from 43.3 on March 2023 to 46.4 on March 2026 . This represents a CAGR of 1.74% over 4 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Global Health Ltd changed from ₹ 14111 crore on March 2023 to ₹ 25850 crore on March 2026 . This represents a CAGR of 16.34% over 4 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Global Health Ltd for the Jun '26 is ₹ 1326 crore as compare to the Mar '26 revenue of ₹ 1195 crore. This represent the growth of 10.91% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Global Health Ltd for the Jun '26 is ₹ 308.92 crore as compare to the Mar '26 ebitda of ₹ 280.51 crore. This represent the growth of 10.13% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Global Health Ltd changed from ₹ 106.26 crore to ₹ 157.25 crore over 9 quarters. This represents a CAGR of 19.03% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Global Health Ltd changed from 2.71 % on March 2026 to 2.71 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Global Health Ltd

Global Health Limited (GHL) was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Company.
The status of the Company got converted into a Public Limited Company and the name was changed to Global Health Limited' dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in providing healthcare services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon.
The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly.

FAQs for the comparison of 3B Blackbio DX Ltd and Global Health Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Global Health Ltd?

Market cap of 3B Blackbio DX Ltd is 1,144 Cr while Market cap of Global Health Ltd is 31,850 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Global Health Ltd?

The stock performance of 3B Blackbio DX Ltd and Global Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Global Health Ltd?

As of October 24, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1332.95. On the other hand, Global Health Ltd stock price is INR ₹1184.6.

How do dividend payouts of 3B Blackbio DX Ltd and Global Health Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Global Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.